Ivanhoe - Dr. Giulio Maria Pasinetti: “Possible Alzheimer's Vaccine”

New York, NY
 – April 27, 2012 /Press Release/  –– 

Alzheimer’s disease (AD) is the leading cause of dementia in the elderly and is an incurable disease that affects more than five million people. Now intravenous human immunoglobulin (IVIG) treatment is currently being explored for uses other than immunotherapy, including AD. Recent studies by Dr. Giulio Maria Pasinetti, Saunders Family Chair and Professor in Neurology and Psychiatry at Mount Sinai School of Medicine, demonstrate that the diverse outcomes in AD studies of IVIG may be due to differences in temporal administration and administered doses. “This experimental observation provides a rational basis for rectifying the inconsistency of study outcomes in Alzheimer's disease clinical trials with IVIG. We now have the much needed information supporting the potential application of slow release of immunoglobulin’s delivered subcutaneously to delay the onset of Alzheimer's disease, even at pre-symptomatic stages of the disease," said Dr. Pasinetti. Learn more